Overview

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of fixed combination of amlodipine(5mg or 10mg) and losartan (50 mg or 100 mg), amlodipine and losartan alone in reducing blood pressure. The study will investigate the dose response relationship for the combinations and monotherapies.
Phase:
Phase 2
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Amlodipine
Losartan